Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Tubular Breast Cancer|Mucinous Breast Cancer|Invasive Duct Carcinoma of Breast
Interventions: DRUG: Paclitaxel, Cisplatin|DRUG: EC to docetaxel or paclitaxel
Sponsor: RenJi Hospital